ペプチド
抗体
色素試薬
PROTAC
バーチャルスクリーニング
Targetmolキット
Cell Counting Kit-8 (CCK-8)
Inhibitor Cocktails
天然化合物
フェノール類
アルカロイド類
フラボノイド類
阻害剤
血管新生
アポトーシス
オートファジー
細胞周期・チェックポイント
クロマチン・エピジェネティック
細胞骨格シグナル
DNA損傷・DNA修復
内分泌・ホルモン
GPCR/Gタンパク質
免疫・炎症
JAK・STATシグナル
These include those focused libraries of small-molecule compounds with their specific applications (Antibiotics Library, CNS-Penetrant Compound Library, DNA Damage & Repair Compound Library, Neural Regeneration Compound Library, PPI Inhibitors Library, etc.).
| カタログ番号 | 製品名 | ||
|---|---|---|---|
| L7500 | Coagulation and Anticoagulation Compound Library | A unique collection of 154 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); | 154 compounds |
| L7000 | Bioactive Lipid Compound Library | A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa | 385 compounds |
| L9001 | Food Additive Library | 430 compounds | |
| L7700 | Neural Regeneration Compound Library | A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening; | 529 compounds |
| L2900 | Oxidation-Reduction Compound Library | 1279 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening. | 1279 compounds |
| L2540 | Gut Microbial Metabolite Library | A unique collection of 352 gut microbial metabolites which can be used for HTS and HCS; | 352 compounds |
| L9411 | Cysteine Covalent Library | The cysteine covalent library contains 72 compounds. | 72 compounds |
| L5800 | Drug Metabolite/Impurity Library | A unique collection of 200 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS); | 200 compounds |
| L9600 | Peptide Compound Library | 533 peptides can be used in peptide drug development and signaling transduction and mechanism study; | 533 compounds |
| L5900 | CNS-Penetrant Compound Library | A unique collection of 516 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS); | 516 compounds |
| L9820 | Beta-Lactam Compound Library | A unique collection of 105 beta-lactam compounds, can be used in HTS and HCS; | 105 compounds |
| L5510 | Drug-induced Liver Injury (DILI) Compound Library | A unique collection of 1040 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening； | 1040 compounds |
| L9210 | Pediatric Drug Library | A unique collection of 1015 pediatric drugs for high-throughput screening and high-content screening. | 1015 compounds |
| L2510 | Lipid Metabolism Compound Library | A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | 496 compounds |
| L2521 | Glycolysis Compound Library | 560 glycolysis-related active compounds for high-throughput and high-content screening. | 560 compounds |
| L4900 | Cardiotoxicity Compound Library | A unique collection of 127 cardiotoxicity inducing compounds for toxicological study; | 127 compounds |
| L3100 | Hematopoietic Toxicity Compound Library | A unique collection of 104 compounds with defined hematopoietic toxicity for high throughput and high content drug screening; | 104 compounds |
| L9610 | Cyclic Peptide Library | 58 species of cyclic peptide molecules for high-throughput and high-content screening; | 58 compounds |
| L3500 | Histone Modification Compound Library | A unique collection of 362 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); | 362 compounds |
| L5500 | Toxic Compound Library | A unique collection of 277 toxic substances for high throughput screening (HTS) and high content screening (HCS); | 277 compounds |
| L5100 | Fluorochemical Library | A unique collection of 583 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS); | 583 compounds |
| L9410 | Covalent Inhibitor Library | A unique collection of 941 covalent Inhibitors and other molecules with common warheads like chloroacetyl，2-Chloropropionyl，Acryloyl，sulfonyl fluoride, alkyne，acrylamide, ketocarbonyl，disulfide bond, etc. | 941 compounds |
| L2400 | Endocrinology-Hormone Compound Library | A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | 813 compounds |
| L2560 | Metabolism Compound Library | A unique collection of 2350 metabolic pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | 2350 compounds |
| L2570 | Human Metabolite Library | A unique collection of 4532 human metabolites for high-throughput, high-content screening. | 4532 compounds |
| L9500 | Target-Focused Phenotypic Screening Library | A unique collection of 1832 annotated bioactive compounds with clear targets, suitable for phenotypic screening； | 1832 compounds |
| L4020 | NO PAINS Compound Library | 9555 compounds | |
| L2910 | Antioxidant Compound Library | Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of atherosclerosis, heart failure, myocardial infarction, cancer, infection etc. Antioxidants are a class of compounds that counteract oxidative stress and reduce oxidative damage. The TargetMol Antioxidant Compound Library is a unique collection of 1330 small molecules with inhibitory effects on oxidative stress and is a useful tool for high-throughput screening and high-content screening in the study of oxidative stress. | 1330 compounds |
| L8110 | Reprogramming Compound Library | A unique collection of 1840 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | 1840 compounds |
| L9230 | ReFRAME Related Library | A unique collection of 3274 compounds for high-throughput screening and high-content screening, | 3274 compounds |
| L4400 | Antibiotics Library | A unique collection of 708 compounds with antibiotic activity for new antibacterial drug screening; | 708 compounds |
| L7900 | Osteogenesis Compound Library | A unique collection of 320 osteogenesis related compounds for high throughput and high content screening; | 320 compounds |
| L3980 | DNA Damage and Repair Compound Library Plus | Well-chosen 667 compounds with unique structures targeting DNA damage & repair; | 667 compounds |
| L9300 | Macrocyclic Compound Library | 216 macrocyclic compounds of known activity for high-throughput, high-content screening; | 216 compounds |
| L1720 | Nucleotide Compound Library | A unique collection of 337 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs; | 337 compounds |
| L2500 | Human Endogenous Metabolite Library | A unique collection of 1400 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening; | 1400 compounds |
| L2520 | Glycometabolism Compound Library | 708 glycometabolism-related comounds, can be used for HTS and HCT; | 708 compounds |
| L2550 | Glutamine Metabolism Compound Library | A unique collection of 580 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer; | 580 compounds |
| L9850 | Orally Active Compound Library | A unique collection of 2484 of orally active compounds for high-throughput screening and high-content screening. | 2484 compounds |
| L8000 | Stem Cell Differentiation Compound Library | A unique collection of 1213 stem cell differentiation signaling targeted compounds for high throughput and high content screening; | 1213 compounds |
| L1380 | Transcription Factor-Targeted Compound Library | Well-chosen 704 compounds with unique structures targeting transcription factor; | 704 compounds |
| L2530 | Mouse Metabolite Compound Library | A unique collection of 224 mouse metabolites, which can be used for HTS and HCS; | 224 compounds |
| L9400 | PPI Inhibitor Library | A unique collection of 490 PPI-related compounds for drug screening; | 490 compounds |
| L9900 | Inactive Ingredient Library | 184 compounds | |
| L8300 | Chromatin Modification Compound Library | A unique collection of 256 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS); | 256 compounds |
